Stock NKTR NEKTAR THERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Nektar Therapeutics

Equities

NKTR

US6402681083

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-23 EDT 		5-day change 1st Jan Change
1.66 USD -5.14% Intraday chart for Nektar Therapeutics -7.78% +193.81%
05-09 Earnings Flash (NKTR) NEKTAR THERAPEUTICS Reports Q1 Revenue $21.6M, vs. Street Est of $15.3M MT
05-09 Transcript : Nektar Therapeutics, Q1 2024 Earnings Call, May 09, 2024
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
NEKTAR THERAPEUTICS Stock Nektar Therapeutics
 305M -
ELI LILLY AND COMPANY Stock Eli Lilly and Company
 728B
NOVO NORDISK A/S Stock Novo Nordisk A/S
 603B
JOHNSON & JOHNSON Stock Johnson & Johnson
 360B
MERCK & CO., INC. Stock Merck & Co., Inc.
 332B
ABBVIE INC. Stock AbbVie Inc.
 279B
  1. Stock Market
  2. Equities
  3. NKTR Stock
  4. Charts Nektar Therapeutics
  5. Sector Chart